Published in Neurology on January 15, 2008
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science (2008) 11.74
Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology (2012) 1.91
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nat Rev Drug Discov (2012) 1.47
Adenosine dysfunction in epilepsy. Glia (2011) 1.14
Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem Pharmacol (2009) 1.03
Methylxanthines, seizures, and excitotoxicity. Handb Exp Pharmacol (2011) 0.99
Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics (2009) 0.98
Localization of plasma membrane bound NTPDases in the murine reproductive tract. Histochem Cell Biol (2009) 0.96
Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction. Mol Neurodegener (2009) 0.91
High expression and activity of ecto-5'-nucleotidase/CD73 in the male murine reproductive tract. Histochem Cell Biol (2010) 0.85
Bench-to-bedside review: adenosine receptors--promising targets in acute lung injury? Crit Care (2008) 0.85
Mechanisms of sudden unexplained death in epilepsy. Curr Opin Neurol (2015) 0.79
Adenosinergic depression of glutamatergic transmission in the entorhinal cortex of juvenile rats via reduction of glutamate release probability and the number of releasable vesicles. PLoS One (2013) 0.79
Adenosine neuromodulation and traumatic brain injury. Curr Neuropharmacol (2009) 0.78
Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery. Seizure (2010) 0.78
Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia. Neuroreport (2012) 0.78
Hide and seek: a comparative autoradiographic in vitro investigation of the adenosine A3 receptor. Eur J Nucl Med Mol Imaging (2015) 0.76
A scaffold as a platform for new therapies? Epilepsy Curr (2012) 0.75
[18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents. Eur J Nucl Med Mol Imaging (2015) 0.75
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients. Sci Rep (2017) 0.75
Descending monoaminergic pain modulation: bidirectional control and clinical relevance. Neurology (2008) 0.96
CGRP: sensory neuropeptide with multiple neurologic implications. Neurology (2011) 0.96